首页> 外文期刊>Biochemical and Biophysical Research Communications >Global and focused transcriptional profiling of small molecule aminopeptidase N inhibitor reveals its mechanism of angiogenesis inhibition.
【24h】

Global and focused transcriptional profiling of small molecule aminopeptidase N inhibitor reveals its mechanism of angiogenesis inhibition.

机译:小分子氨基肽酶N抑制剂的全球和重点转录谱揭示了其抑制血管生成的机制。

获取原文
获取原文并翻译 | 示例
           

摘要

We recently developed a specific small molecule inhibitor of aminopeptidase N (APN), named as HNSA, through a high throughput screening. In the present study, we investigated the major cellular phenotypes of HNSA in comparison with those of APN knock-down in human fibrosarcoma cells and the mechanism of angiogenesis inhibition by the compound using DNA microarray analyses. Global gene expression analyses showed that HNSA signatures are significantly correlated with those of APN knock-down in HT1080 cells, suggesting that APN is a primary target of HNSA in the cells. Using the angiogenesis-focused DNA microarrays, nine of angiogenesis-related genes were identified as crucial mediators of angiogenesis inhibition by HNSA. These data demonstrate that HNSA can be used as a valuable tool to decipher the APN function in angiogenesis.
机译:我们最近通过高通量筛选开发了一种特定的小分子氨基肽酶N(APN)抑制剂,称为HNSA。在本研究中,我们使用DNA芯片分析研究了HNSA的主要细胞表型与人纤维肉瘤细胞中APN敲低的细胞表型以及该化合物抑制血管生成的机制。全局基因表达分析表明,HNSA签名与HT1080细胞中APN敲低显着相关,这表明APN是细胞中HNSA的主要靶标。使用聚焦于血管生成的DNA微阵列,已确定9种与血管生成相关的基因是HNSA抑制血管生成的重要介质。这些数据表明,HNSA可用作破译血管生成中APN功能的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号